Journals / Medicine Science / 2017 / Cilt: 6 - Sayı: 1

Evaluation of the early results of ab interno trabeculectomy surgery appllied with trabectome device

Pages
11–16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This procedure is an appropriate surgical alternative for patients that targeted to have IOP at moderate levels without need for any topical medication or with less topical medication

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of the current study was to assess efficacy and safety of ab interno trabeculectomy surgery applied with trabectome device in early period.
📊
Key Findings & Data:The study was designed among the 30 eyes of 26 patients who had undergone trabectome surgery with the diagnosis of open-angle glaucoma.
💡
Conclusion & Impact:This procedure is an appropriate surgical alternative for patients that targeted to have IOP at moderate levels without need for any topical medication or with less topical medication
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of the current study was to assess efficacy and safety of ab interno trabeculectomy surgery applied with trabectome device in early period. The study was designed among the 30 eyes of 26 patients who had undergone trabectome surgery with the diagnosis of open-angle glaucoma. Patients were evaluated as retrospectively in terms of preoperative and postoperative intraocular pressure (IOP), number of drugs used and complications. While the preoperative mean IOP was 28.78±5.57 mmHg (n:30) with the mean number of medications 3.40±1.04, the mean IOP was 18.24±5.54 mmHg (n:30) with the mean number of medications 0.90±1.27 at 1st month. At 3rd month the mean IOP was 16.37±3.36 mmHg (n:28) with the mean number of medications 0.70±1.10 and at 6th month the mean IOP was 16.51±3.80 mmHg (n:28) with the mean number of medications 1.13±0.96. When postoperative measurements compared with preoperative values, detected reductions in IOP and number of medications were statistically significant (p<0.01). Postoperatively decrease in IOP was 40% at 1st month, 38.1% at 3rd month and 33.4% at 6th month while the reduction in the number of medications was 73.5% at 1st month, 79.8% at 3rd month and 65.8% at 6th month. Trabectome surgery is a effective and safe option for open-angle glaucoma. This procedure is an appropriate surgical alternative for patients that targeted to have IOP at moderate levels without need for any topical medication or with less topical medication

🔖

Cite This Article

DÜZGÜN, E., YILDIRIM, Y., ÇAKIR, A., ÜNAL, M. H., AYATA, A., SÖNMEZ, M. (2017). Evaluation of the early results of ab interno trabeculectomy surgery appllied with trabectome device. Medicine Science, Cilt: 6 - Sayı: 1, 11–16. https://ajindex.com/articles/277368

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tsai JC, Johnson CC, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome. Ophthalmology. 2003;110(9):1814-21
  2. Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL; Tube versus Trabeculectomy Study Group.Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789-803
  3. Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96-104
  4. Minckler D, Baerveldt G, Ramirez MA, Mosaed S, Wilson R, Shaarawy T, Zack B, Dustin L, Francis B. Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma. Trans Am Ophthalmol Soc. 2006;104:40-50
  5. Francis BA, See RF, Rao NA, Minckler DS, Baerveldt G. Ab interno trabeculectomy: Development of a novel device (Trabectome) and surgery for open-angle glaucoma. J Glaucoma. 2006;15(1):68-73
  6. Nguyen QH. Trabectome: A novel approach to angle surgery in the treatment of glaucoma. Int Ophthalmol Clin. 2008;48(4):65–72
  7. Chihara E, Nishida A, Kodo M, Yoshimura N, Matsumura M, Yamamoto M, Tsukada T. Trabeculotomy ab externo: an alternative treatment in adult patients with primary open-angle glaucoma. Ophthalmic Surg. 1993;24(11):735-9
  8. Barkan O. Surgery of congenital glaucoma; review of 196 eyes operated by goniotomy. Am J Ophthalmol. 1953;36(11):1523-34
  9. Ichhpujani P.,Moster MR. Novel Glaucoma Surgical Devices, Dr Shimon Rumelt Ed.Glaucoma - Basic and Clinical Concepts, InTech, 2011,C:20:417-42
  10. Minckler DS, Baerveldt G, Alfaro MR, Francis BA. Clinical results with the Trabectome for treatment of open-angle glaucoma. Ophthalmology. 2005;112(6):962-7
  11. Minckler D, Mosaed S, Dustin L, Ms BF; Trabectome Study Group.Trabectome (trabeculectomy- internal approach): additional experience and extended follow-up. Trans Am Ophthalmol Soc. 2008;106:149-59
  12. Ting JLM, Damji KF, Stiles MC;Trabectome Study Group. Ab interno trabeculectomy: Outcomes in exfoliation versus primary open-angle glaucoma. J Cataract Refract Surg. 2012;38(2):315-323
  13. Ahuja Y, Ma Khin Pyi S, Malihi M, Hodge DO, Sit AJ. Clinical Results of Ab Interno Trabeculotomy Using the Trabectome for Open-Angle Glaucoma: The Mayo Clinic Series in Rochester, Minnesota, Am J Ophthalmol. 2013;156(5):927–35
  14. Altan-Yaycioglu R, Canan H, Pelit A, Akova YA. Intraocular pressure after phacoemulsif